Donaldson buys biotech Isolere Bio

Filtration manufacturer Donaldson Co. (NYSE:DCI) has purchased early-stage biotech Isolere Bio.

The deal expands Minneapolis-based Donaldson’s life sciences business. Durham, North Carolina-based Isolere Bio develops new and proprietary IsoTag reagents and filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals.

“Aimed initially at the purification of viral vectors used for cell and gene therapies, IsoTag reagents are designed to substantially improve product quality and purity with faster timelines compared to competing solutions, enabling accelerated and more affordable delivery of life-changing therapies to patients globally,” Donaldson said in a news release.

Donaldson Chair, President and CEO Tod Carpenter said the acquisition positions Donaldson “to create premier separation and filtration solutions for emerging genetic-based drugs.”

Donaldson also recently purchased So…

Read more
  • 0

Trelleborg to expand biopharma manufacturing footprint in Europe

NEWS RELEASE: Trelleborg to Expand its BioPharma Manufacturing Footprint in Europe

This rendering shows Trelleborg’s plans for its Malta expansion. [Illustration courtesy of Trelleborg]

Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities in Malta. This follows a multimillion-dollar investment initiated in 2022 to expand biopharma capacities in North America.

Linda Muroski, President of Trelleborg Healthcare & Medical, says: “The site will initially add over 4,000 square feet of cleanroom space and focus on silicone tubing and braided hose with options to extend capabilities in the future. This is our second biopharma-focused manufacturing space alongside our BioPharma Center of Excellence in Northborough, Massachusetts in the U.S.”

The Malta site is one of Trelleborg’s largest manufacturing sites in Europe wi…

Read more
  • 0